|
Bliss GVS Pharma Ltd |
Pharmaceuticals - Indian - Formulations |
|
|
BSE Code |
|
506197 |
|
|
|
ISIN Demat |
|
INE416D01022 |
|
|
|
Book Value |
|
93.382807 |
|
|
|
Mar.Cap(Rs.Cr) |
|
1,295.03 |
|
|
|
P/E |
|
18.97 |
|
|
|
Face Value |
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Years | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Debt-Equity Ratio | 0.10 | 0.11 | 0.13 | 0.13 | 0.14 | Long Term Debt-Equity Ratio | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | Current Ratio | 4.09 | 4.07 | 4.55 | 5.18 | 4.68 | Fixed Assets | 1.82 | 2.64 | 2.25 | 2.97 | 4.78 | Inventory | 7.29 | 7.32 | 6.45 | 7.66 | 9.01 | Debtors | 1.48 | 1.68 | 1.24 | 1.18 | 1.37 | Interest Cover Ratio | 12.50 | 30.26 | 22.76 | 19.39 | 39.10 | PBIDTM (%) | 23.55 | 22.72 | 23.45 | 31.04 | 30.22 | PBITM (%) | 21.02 | 20.54 | 20.49 | 29.04 | 28.87 | PBDTM (%) | 21.87 | 22.04 | 22.55 | 29.54 | 29.48 | CPM (%) | 16.82 | 16.74 | 17.46 | 22.89 | 18.80 | APATM (%) | 14.29 | 14.56 | 14.50 | 20.89 | 17.45 | ROCE (%) | 12.81 | 14.59 | 11.71 | 17.64 | 18.75 | RONW (%) | 9.56 | 11.53 | 9.38 | 14.36 | 13.00 |
|
|
|
|